399
Men with syphilis enrolled
201
Control group without syphilis
In 1932, the U.S. Public Health Service (PHS) launched a study in Macon County, Alabama — one of the poorest counties in the country, with almost no access to medical care for Black residents. The stated purpose was to document the progression of untreated syphilis in Black men, based on a racist scientific hypothesis that the disease manifested differently in Black people than in white people (an assumption with no scientific basis).
The men enrolled were not told they had syphilis. They were told they had "bad blood" — a local term for various ailments — and that the government would provide them with free medical care, free meals on examination days, and burial insurance. These were significant benefits for sharecroppers in the Depression South who had never had access to a doctor. They were not told they were in an experiment. They were not told the experiment was designed to watch them deteriorate and die.
"The men were never given adequate treatment for their disease. Even when penicillin became the drug of choice for syphilis in 1947, researchers did not offer it to the study participants."
— Centers for Disease Control and Prevention, official history
By 1947, penicillin had become the standard treatment for syphilis — a simple, cheap, effective cure. The PHS knew this. The study's researchers knew this. They continued the study anyway, because treating the participants would end the experiment. They also took active steps to prevent the participants from receiving treatment from other sources: when the men were called up for the draft in World War II, the PHS contacted local draft boards to ensure they were not given the standard syphilis treatment administered to all draftees.
Between 1947 and 1972, the study continued as the men's conditions progressed. Participants went blind. They suffered cardiac damage. They developed neurological disorders. Twenty-eight died directly from syphilis. One hundred died from related complications. Forty wives were infected. Nineteen children were born with congenital syphilis — a condition that did not have to exist, since their fathers could have been cured before they were conceived.
At no point did any federal official stop the study on ethical grounds. It passed every annual review. It was presented at scientific conferences. It was published in peer-reviewed medical journals. Everyone involved knew what was happening.
Peter Buxtun was a PHS venereal disease investigator who first raised ethical objections to the study internally in 1966. He sent a formal memo to the PHS's chief of venereal disease, arguing that the study violated the Nuremberg Code principles — the ethics standards developed after Nazi medical experiments were prosecuted at the Nuremberg Trials. He was told the study would continue. He raised objections again in 1968. He was ignored again.
In 1972, Buxtun gave study documents to Associated Press reporter Jean Heller. On July 25, 1972, Heller's story ran on the front pages of newspapers across the country. Public outrage was immediate. Within months, the study was terminated. Senator Edward Kennedy held congressional hearings. The surviving participants — 74 men — finally received treatment, 40 years after they had enrolled and 25 years after penicillin had been available.
In 1973, a class action lawsuit resulted in a $10 million settlement. In 1997, President Clinton issued a formal apology at the White House, with five of the eight surviving participants present. Fred Gray, one of the participants' attorneys, said: "It can never make up for the harm that was done."
3×
Higher Black maternal mortality rate vs. white
40%
Lower COVID vaccine uptake in some Black communities (early rollout)
Economists Marcella Alsan and Marianne Wanamaker published a landmark 2018 study in the Quarterly Journal of Economics demonstrating that the disclosure of the Tuskegee Study in 1972 caused a measurable decline in Black men's engagement with the healthcare system — and that this decline explained up to 35 percent of the gap in Black-white male life expectancy in the 1980s. The study was still killing people a decade after it ended.
Black Americans are more likely to delay seeking care, more likely to distrust physician recommendations, and more likely to decline preventive interventions than white Americans, even when controlling for income, education, and insurance status. Public health researchers consistently cite Tuskegee — along with a broader history of non-consensual medical experimentation on Black bodies — as a primary driver. This is not irrational. It is an evidence-based threat assessment.
The Tuskegee Study is not a historical curiosity. It is a living causal factor in the Black-white health disparity that kills people every year. The men in the study were harmed. Their children were harmed. The communities who learned of the study were harmed. And the harm compounds forward.
"The legacy of Tuskegee is not just memory. It's a rational calculation: the government has deliberately harmed Black people using medicine before. The possibility that it might do so again is not paranoia — it is pattern recognition."
— Marcella Alsan, Stanford Medical School economist